萘酚喹

Naphthoquine

未知生产厂商

Naphthoquine is under investigation in clinical trial NCT01930331 (Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO).

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Naphthoquine is under investigation in clinical trial NCT01930331 (Safety, Tolerability, Pharmacokinetics and Efficacy of ARCO).

技术标识符

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

USE OF NAPHTHOQUINE PHOSPHATE IN PREPARATION OF MEDICAMENT FOR TREATING AUTOIMMUNE DISEASES
EP 4559464 A4申请人: SHANGHAI PHARMACEUTICALS IND CO LTD优先权: 2022
CN
EP
US
WO
4 件公开
Novel compound antimalarial preparation method
CN 1520822 A申请人: SHEN HENG优先权: 2003
CN
Malaria-resisting arteannuin naphthoquine compound composition
CN 101116665 B申请人: GUOQIAO LI优先权: 2006
CN
Antimalarial green tea chewing gum
CN 101623296 A申请人: XINGUANG QIAO优先权: 2008
CN
4-(7-chlorine-4aminoquinoline)-5,6,7,8-tetrahydro-alpha-naphthol derivatives, preparation method and application thereof
CN 102229564 A申请人: AMMS CHINA优先权: 2011
CN
种萘酚喹盐类制备新工艺
CN 105085505 B申请人: 昆药集团股份有限公司优先权: 2014
CN
种磷酸萘酚喹的用途
CN 104666300 B申请人: 昆药集团股份有限公司优先权: 2014
CN
Artesunate and naphthoquine combined composition for treating malignant malaria
CN 108245514 A申请人: HUBEI SENDO STAR BIO TECH CO LTD优先权: 2016
CN
Naphthoquine phosphate process impurity and synthesis method thereof
CN 109503479 A申请人: SICHUAN ZIHAO TIMES PHARMACEUTICAL CO LTD优先权: 2018
CN
磷酸萘酚喹在制备治疗病毒引起的疾病的药物中的应用
CN 113143927 B申请人: 成都自豪药业有限公司优先权: 2020
CN